Published in J Am Acad Dermatol on October 01, 2002
Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol (2009) 1.49
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Arthritis Res Ther (2004) 1.09
Expression of vascular endothelial growth factor and its receptors in rosacea. Br J Ophthalmol (2007) 0.92
Matrix metalloproteinases in inflammatory bowel disease: an update. Mediators Inflamm (2015) 0.87
Dermal vasculature in psoriasis and psoriasiform dermatitis: a morphometric study. Indian J Dermatol (2011) 0.79
Matrilin-1 is an inhibitor of neovascularization. J Biol Chem (2014) 0.78
Proteoglycans in Normal and Healing Skin. Adv Wound Care (New Rochelle) (2015) 0.76
Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941. J Urol (2007) 1.13
Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancer. Clin Lung Cancer (2003) 0.90
The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. Clin Cancer Res (2002) 0.87
Biologic therapy in psoriasis: perspectives on associated risks and patient management. J Cutan Med Surg (2012) 0.86
Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer. J Clin Oncol (2004) 0.78
North American Contact Dermatitis Group patch test results for 2007-2008. Dermatitis (2013) 0.77
Additive value of patch testing custom epoxy materials from the workplace at the occupational disease specialty clinic in Toronto. Dermatitis (2012) 0.76
Transarterial embolization of symptomatic focal nodular hyperplasia. J Vasc Interv Radiol (2013) 0.76
Adrenal tuberculosis revealed by FDG PET. Clin Nucl Med (2008) 0.75